- Dai-Ichi Life’s net income for the first quarter was 43.18 billion yen, which fell short of the estimated 92.95 billion yen.
- Despite the first quarter miss, the company maintains its forecast for the year with a projected net income of 347.00 billion yen, below the market estimate of 376.48 billion yen.
- Dai-Ichi Life also continues to expect net sales of 9.16 trillion yen, which is lower than the estimated 9.59 trillion yen.
- The company retains its dividend forecast at 48.00 yen per share, which is very close to the estimate of 48.26 yen.
- Analyst recommendations for Dai-Ichi Life include 8 buy ratings, 4 hold ratings, and 1 sell rating.
- Comparisons are drawn from the values reported by the company’s original disclosures.
A look at Dai Ichi Life Insurance Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Smartkarma’s analysis of Dai Ichi Life Insurance indicates a positive long-term outlook for the company. With a solid 4 out of 5 score in the Dividend category, investors can expect good returns through dividend payouts. Additionally, the company scored 3 out of 5 in Value, Growth, Resilience, and Momentum, showcasing a balanced performance across these key factors. This suggests that Dai Ichi Life Insurance is well-positioned to weather market fluctuations and maintain steady growth over time.
The Dai-ichi Life Insurance Company Ltd. is a reputable provider of life, health, and annuity insurance, catering to both group and individual clients. Offering a diverse range of insurance products tailored to different needs, from securing children’s education to providing financial security for the elderly, Dai Ichi Life Insurance demonstrates a commitment to addressing a variety of customer requirements and promoting financial well-being.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
